Tag: Cancer: Ovarian
Computed Tomography Features Vary Based on BRCA Status
Differences seen between BRCA-mutant versus BRCA wild-type high-grade serous ovarian cancer
Hospital Volume, Quality Impact Survival in Ovarian Cancer
Survival lower for lower volume hospitals with higher quality scores versus higher volume hospitals
USPSTF: Ovarian Cancer Screen to Be Avoided for Most Women
Test isn't accurate enough to justify its use, U.S. Preventive Services Task Force says
New VTE Often Occurs During Chemo in Ovarian Cancer
Most cases of venous thromboembolism occurred during neoadjuvant or adjuvant chemotherapy
Hypertension May Positively Affect Ovarian Cancer Prognosis
Linked to 46 percent lower risk of progression for women with endometrioid ovarian cancer
Survival Similar With Debulking by Laparotomy, Laparoscopy
Similar three-year survival rates for women with epithelial ovarian cancer undergoing debulking
Cediranib Tx in Relapsed Ovarian CA Doesn’t Lower Quality of Life
Findings among women on maintenance therapy for relapsed ovarian cancer
BRCA Mutation Testing Shifts to Unaffected Women
From 2004 to 2014, greater percent of testing in unaffected women versus cancer patients
FDA Approves Zejula for Certain Female Cancers
PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum
Hormonal Maintenance Tx Ups PFS in Low-Grade Serous Cancer
Significantly longer progression-free survival in low-grade serous carcinoma of the ovary or peritoneum
